Case report: Successful outcome of COVID-19 in the context of autologous hematopoietic stem cell transplantation: The impact of the anti-SARS-CoV-2 vaccine and early remdesivir

Case report: Successful outcome of COVID-19 in the context of autologous hematopoietic stem cell transplantation: The impact of the anti-SARS-CoV-2 vaccine and early remdesivir

Coronavirus disease (COVID-19) in patients undergoing hematopoietic stem cell transplantation (HSCT) is a major issue. None of the published papers have reported data on the outcome of HSCT patients with COVID-19 according to the vaccination status and the short course of remdesivir (RDV). Therefore...

Full description

Bibliographic Details
Main Authors: Angioletta Lasagna, Antonio Piralla, Simona Secondino, Paolo Sacchi, Fausto Baldanti, Raffaele Bruno, Paolo Pedrazzoli
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Medicine
Subjects:
hematopoietic stem cell transplantation (HSCT)
remdesivir
G-CSF
neutropenia
COVID-19
vaccine
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.944855/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.944855/full

Similar Items